Active Substance: Telmisartan
Concentration: 40 mg/tab
Pack Size: 50 tabs
Manufacturer: Deus Medical
Brand Name: Micardis
SKU: P309
Shipping From
TELMIMED 40 contains Telmisartan, an effective antihypertensive medication used to manage high blood pressure. It works by blocking the action of angiotensin II, a substance in the body that causes blood vessels to constrict, thereby allowing blood vessels to relax and widen.
Product Overview
Telmisartan is part of the angiotensin receptor blocker (ARB) class of medications, which are known for their efficacy in reducing blood pressure and lowering the risk of cardiovascular events. TELMIMED 40 is an excellent choice for individuals seeking effective long-term blood pressure management.
Usage and Dosage
The typical dosage for TELMIMED 40 is 40 mg once daily, which can be adjusted by a healthcare provider based on individual response and blood pressure goals. It is essential to take this medication at the same time each day to maintain consistent blood levels.
Side Effects & Management
Common side effects of Telmisartan may include dizziness, fatigue, and gastrointestinal disturbances. While most side effects are mild, users should monitor their health and consult a healthcare provider if they experience significant discomfort or adverse reactions.
Patient Safety Information
This product is intended for adults managing hypertension. It should be used under medical supervision, especially for individuals with a history of renal impairment, heart conditions, or those taking other medications that may interact with Telmisartan.
FAQs
What benefits can I expect from using TELMIMED 40?
Users can expect effective management of high blood pressure, leading to improved cardiovascular health and reduced risk of heart-related complications.
How long does it take to see results?
Many users may notice improvements in blood pressure control within a week of consistent use.
Is TELMIMED 40 safe for long-term use?
Long-term safety is generally well-established for Telmisartan; however, regular follow-up with a healthcare provider is recommended.